Prevalence of atopic dermatitis in children in the city of Goma (Democratic Republic of Congo)


  • Ngolo M. Pascaline Dermatology Department, North Kivu Provincial Hospital, Goma/DRC, Rwanda, Democratic Republic of the Congo
  • Ndayazi B. Désiré Department of Surgery, University of Goma (UNIGOM), Goma/DRC, Rwanda, Democratic Republic of the Congo
  • Atadokpèdé F. Department of Dermatology and Venereology, Faculty of Health Sciences, University of Abomey, Calavi, Bénin
  • Wembonyama O. Stanis School of Public Health, University of Goma (UNIGOM), Goma/DRC, Rwanda, Democratic Republic of the Congo



Prevalence, Atopic dermatitis, City of Goma


Background: Currently, atopic dermatitis is one of the most common chronic inflammatory dermatoses. However, studies concerning its prevalence in children are rare in the Democratic Republic of Congo (DRC). Thus, we proposed to determine the prevalence and sociodemographic factors associated with atopic dermatitis in children.

Methods: We conducted a descriptive cross-sectional study over a 6-month period from June 1 to December 31, 2022. It focused on children aged 0 to 18 years who were brought to the dermatology services of the North Kivu Provincial Hospital (HPNK) for atopic dermatitis. Data were entered and analyzed using SPSS 20 and Epi info 3.5.3 software.

Results: The hospital prevalence of atopic dermatitis in children aged 0-18 years was 12.4%. The 0 to 4 age group was the most affected with 54.4%. Males were the most represented (56.7%). The sex ratio M/F was 1.3. The majority of our patients were from the urban area (72.8%). Atopy (personal or familial) was found in 68.9% of patients and was dominated by asthma (23.9%) and allergic rhinitis (21.1%). The most common trigger was food (30.7%) followed by cosmetics (20.5%). Mean age of symptom onset was 7±2 months. The most represented clinical form was the common or vulgar form with 69.4% of cases. Atopic dermatitis was associated with sleep disorder in 77.8% of cases.

Conclusions: The data presented in our study are also consistent with the literature which states that the prevalence of atopic dermatitis in children ranged from 10 to 20% and was higher in children under 5 years of age living in urban areas.


Bioderma. À quel âge commence la dermatite atopique? Available at: https://www.bioderma. fr/votre-peau/peau-seche-atopique/peau-irritee-avec-demangeaisons-atopique/age-dermatite#:~:text= En%20règle%20générale%2C%20la%20dermatite,dans%205%20%25%20après%2040%20ans. Accessed on 17 February 2023.

Bridget P. Kaufman. AD in diverse racial and ethnic groups-variations in epidemiology, genetics, clinical presentation and treatment. Experiment Dermatol. 2018;27(7):340-57.

Al-Naqeeb J, Danner S, Fagnan LJ, Ramsey K, Michaels L, Mitchell J, et al. The Burden of Childhood AD in the Primary Care Setting: A Report from the Meta-LARC Consortium. J Am Board Fam Med. 2019;32(2):191-200.

Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of AD in adults: Results from an international survey. Allergy. 2018;73(6):1284-93.

Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol. 2013;133:1752-9.

Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about AD. J Allergy Clin Immunol. 2006;118(1):209-13.

Just J. Histoire naturelle de la dermatite atopique : expérience des cohortes néonatales. Revue française d’allergologie. 2012;52:168-74.

Weil C, Sugerman PB, Chodick G, Liang H, Wang H, Calimlim BM, et al. Epidemiology and economic burden of AD: real-world retrospective data from a large nationwide Israeli healthcare provider database. Adv Ther. 2022;39(6):2502-14.

Kowalska-Olędzka E, Czarnecka M, Baran A. Epidemiology of AD in Europe. J Drug Assess. 2019;8(1):126-8.

Jonathan I. Silverberg MD, Barbarot S, Gadkari A,. AD in the pediatric population. Ann Allergy Asthma Immunol. 2021;126:417-28.

Taieb A. Dermatite atopique: definition, épidémiologie, histoire naturelle, gravité et scores. Ann Dermatol Venereol. 2005;132:135-43.

Schmid-Grendelmeier P, Takaoka R, Ahogo KC, Belachew WA, Brown SJ, Correia JC, et al. Position Statement on AD in Sub‐Saharan Africa: current status and roadmap. J Eur Acad Dermatol Venereol. 2019;33(11):2019-28.

Muteba BC, Boye R. Epidemiology of eczemas in childhood in Kinshasa. Actadermato. Venereologica. 2022;102(223):0001-5555.

Ballouk F. La prévalence de la dermatite atopique dans la région de Khouribga. (Thèse de médecine) Université de Marrakech. 2019:64.

Ahogo KC, Kouassi YI, Gbery IP. AD in children: epidemiological and topic dermatitis in children: epidemiological and clinical aspects in Côte d'Ivoire. Dermatol Online. 2017;8(1):25-7.

Dermatite atopique. Généralités, 2020. Available at: Accessed on 17 February 2023.

Barnes KC. An Update on the Genetics of Atopic Dermatitis: Scratching the Surface in 2009. J Allergy Clin Immunol. 2010;125(1):16-31.

Murota H, Katayama I. Exacerbating factors of itch in AD. Allergol Int. 2017;66(1):8-13.

Shiohara T, Mizukawa Y, Shimoda-Komatsu Y, Aoyama Y. Sweat is a most efficient natural moisturizer providing protective immunity at points of allergen entry. Allergol Int. 2018;67(4):442-7.

Atadokpèdé F, Yédomon H, Adégbidi H, Agbéssi N, Soumah H, Diane F. Aspects épidémiologiques de la dermatite atopique dans deux services de Dermatologie à Cotonou-Bénin. Guinée Médicale. 2011;72:1-5.

Panduru M, Salavastru CM, Panduru NM, Tiplica GS. Birth Weight and AD: Systematic Review and Meta-analyis. Acta Dermatovenerol Croat. 2014;22(2):91-6.

Mubanga M, Lundholm C, Rohlin ES, Rejnö G, Brew BK, Almqvist C. Mode of delivery and offspring AD in a Swedish nationwide study. Pediatr Allergy Immunol. 2023;34(1):13904.

Pesonen M. L’allaitement maternel exclusif prolongé est associé à une augmentation de la dermatite atopique : une étude prospective de suivi de nouveaux-nés en bonne santé non sélectionnés de la naissance à l’âge 20 ans. Clin Experiment Allergy. 2006;36(8):1011-8.

Mahfoudh A, Zaraa I, Amara T, Zribi H, El Euch D, Mokni M, et al. Severe childhood AD. La Tunisie Médicale. 2014;92(4):249-52.

Tay YK, Khoo BP, Goh CL. The profile of AD in a tertiary dermatology out patient clinic in Singapore. Int J Dermatol. 1999;38(9):689-92.

Meneghini CL, Bonifazi E. Correlation between clinical and immunological findings in AD. Acta Derm Venerol. 1985;114:140-2.






Original Research Articles